Magazine Article
| February 1, 2017

Getting An Accurate Count Of Counterfeit Drugs

Source: Life Science Leader

By Camille Mojica Rey, Contributing Writer

This is the first article in a four-part Life Science Leader series examining the current state of the counterfeit medicines problem. Upcoming stories will examine the issue from the perspective of industry giant Pfizer, look at what is being done by one international coalition to fight the crime, identify efforts to educate patients, and profile a company working to put unique identifiers on individual pills.